Target Volume Definition for Intensity-modulated Radiotherapy after Induction Chemotherapy and Patterns of Treatment Failure after Sequential Chemoradiotherapy in Locoregionally Advanced Oropharyngeal Squamous Cell Carcinoma

Clinical Oncology

Volumn 25, Issue 3, 2013, Pages 162-170

  Loo, S W ^a   Geropantas, K ^a   Wilson, P ^a   Martin, W M C ^a   Roques, T W ^a  

^a NORFOLK AND NORWICH UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Intensity modulated radiotherapy; Locoregionally advanced oropharyngeal squamous cell carcinoma; Patterns of treatment failure; Sequential chemoradiotherapy; Target volume definition

Indexed keywords

CARBOPLATIN; CISPLATIN; FLUOROURACIL;

ADVANCED CANCER; ARTICLE; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CLINICAL EVALUATION; COMPUTER ASSISTED RADIOTHERAPY; CONTINUOUS INFUSION; DISEASE COURSE; DISEASE SPECIFIC SURVIVAL; DISTANT METASTASIS; FOLLOW UP; HUMAN; INDUCTION CHEMOTHERAPY; INTENSITY MODULATED RADIATION THERAPY; LUNG CANCER; MAJOR CLINICAL STUDY; NECK DISSECTION; OROPHARYNGEAL SQUAMOUS CELL CARCINOMA; OROPHARYNX CARCINOMA; OVERALL SURVIVAL; PRACTICE GUIDELINE; PRIORITY JOURNAL; RADIATION DOSE; RADIATION DOSE DISTRIBUTION; RECURRENCE FREE SURVIVAL; SALVAGE THERAPY; TREATMENT FAILURE; TREATMENT PLANNING; TREATMENT RESPONSE;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CHEMORADIOTHERAPY; CISPLATIN; FLUOROURACIL; HUMANS; INDUCTION CHEMOTHERAPY; NEOPLASM STAGING; OROPHARYNGEAL NEOPLASMS; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, INTENSITY-MODULATED; TREATMENT FAILURE; TREATMENT OUTCOME; TUMOR BURDEN;

EID: 84873087006     PISSN: 09366555     EISSN: 14332981     Source Type: Journal    
DOI: 10.1016/j.clon.2012.07.015     Document Type: Article

References (18)

1. Posner M.R., Hershock D.M., Blajman C.R., et al. Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer. N Engl J Med 2007, 357:1705-1715.
2. Gibson M.K., Forastiere A.A. Reassessment of the role of induction chemotherapy for head and neck cancer. Lancet Oncol 2006, 7:565-574.
3. Salama J.K., Haddad R.I., Kies M.S., et al. Clinical practice guidance for radiotherapy planning after induction chemotherapy in locoregionally advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys 2009, 75:725-733.
4. Gregoire V., Levendag P., Ang K.K., et al. CT-based delineation of lymph node levels and related CTVs in the node-negative neck: DAHANCA, EORTC, GORTEC, NCIC, RTOG consensus guidelines. Radiother Oncol 2003, 69:227-236.
5. Gregoire V., Eisbruch A., Hamoir M., Levendag P. Proposal for the delineation of the nodal CTV in the node-positive and the post-operative neck. Radiother Oncol 2006, 79:15-20.
6. Loo S.W., Geropantas K., Beadsmoore C., Montgomery P.Q., Martin W.M., Roques T.W. Neck dissection can be avoided after sequential chemoradiotherapy and negative post-treatment positron emission tomography-computed tomography in N2 head and neck squamous cell carcinoma. Clin Oncol (R Coll Radiol) 2011, 23:512-517.
7. Dawson L.A., Anzai Y., Marsh L., et al. Patterns of local-regional recurrence following parotid-sparing conformal and segmental intensity-modulated radiotherapy for head and neck cancer. Int J Radiat Oncol Biol Phys 2000, 46:1117-1126.
8. Yao M., Nguyen T., Buatti J.M., et al. Changing failure patterns in oropharyngeal squamous cell carcinoma treated with intensity modulated radiotherapy and implications for future research. Am J Clin Oncol 2006, 29:606-612.
9. Garden A.S., Morrison W.H., Wong P.F., et al. Disease-control rates following intensity-modulated radiation therapy for small primary oropharyngeal carcinoma. Int J Radiat Oncol Biol Phys 2007, 67:438-444.
10. Sanguineti G., Gunn G.B., Endres E.J., Chaljub G., Cheruvu P., Parker B. Patterns of locoregional failure after exclusive IMRT for oropharyngeal carcinoma. Int J Radiat Oncol Biol Phys 2008, 72:737-746.
11. Huang K., Xia P., Chuang C., et al. Intensity-modulated chemoradiation for treatment of stage III and IV oropharyngeal carcinoma: the University of California-San Francisco experience. Cancer 2008, 113:497-507.
12. Daly M.E., Le Q.T., Maxim P.G., et al. Intensity-modulated radiotherapy in the treatment of oropharyngeal cancer: clinical outcomes and patterns of failure. Int J Radiat Oncol Biol Phys 2010, 76:1339-1346.
13. Setton J., Caria N., Romanyshyn J., et al. Intensity-modulated radiotherapy in the treatment of oropharyngeal cancer: an update of the Memorial Sloan-Kettering Cancer Center experience. Int J Radiat Oncol Biol Phys 2012, 82:291-298.
14. Pettit L., Hartley A., Bowden S.J., et al. Variation in volume definition between UK head and neck oncologists treating oropharyngeal carcinoma. Clin Oncol (R Coll Radiol) 2011, 23:654-655.
15. Caudell J.J., Meredith R.F., Spencer S.A., Keene K.S., Dobelbower C., Bonner J.A. Margin on gross tumor volume and risk of local recurrence in head-and-neck cancer. Int J Radiat Oncol Biol Phys 2010, 76:164-168.
16. Pignon J.P., le Maitre A., Maillard E., Bourhis J. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients. Radiother Oncol 2009, 92:4-14.
17. Paccagnella A., Ghi M.G., Loreggian L., et al. Concomitant chemoradiotherapy versus induction docetaxel, cisplatin and 5 fluorouracil (TPF) followed by concomitant chemoradiotherapy in locally advanced head and neck cancer: a phase II randomized study. Ann Oncol 2010, 21:1515-1522.
18. Ang K.K., Harris J., Wheeler R., et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med 2010, 363:24-35.